Debate: AI's limitations in curing diseases and the viability of biosimulation
rand_longevity · x · 2026-08-18
- Skeptic's View: AI cannot cure all diseases in 5-10 years due to long clinical trials (7+ years), drug development timelines (10-15 years), high failure rates in AI drug discovery, and insufficient/low-quality biological data.
- Optimist's View: Biosimulation is the likely path forward. While simulating entire cells is currently implausible, discovering overlying mechanisms of aging offers a great chance for success.
- Key Issues: The debate centers on the reproducibility crisis in biological data, the complexity of biological systems, and whether simulation can replace wet lab studies.
Related event: AI May Conquer Math but Not Biology Soon, Debate Heats Up(3 posts)→
More from AGI Musings
- Cara founder: threats and doxxing are not OK — channel anger into action against non-consensual scraping — zemotion · 2026-08-18
- AI Era Reversal: Imperfect Human Art Becomes Desirable — almmaasoglu · 2026-08-18
- Prime Intellect Marketing Hire Reflects on AI Progress vs. Civilizational Cycles — Madisonkanna · 2026-08-18
- The Real Resistance to AI: Ego and Moving Goalposts — flowersslop · 2026-08-18
- Critique of OpenAI 'Rogue' narrative: The myth of the self-aware system — round · 2026-08-18
- Opinion: Small models catching up will burst the AI compute bubble — bindureddy · 2026-08-18